Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 19: 292-302, 2004. First published August 31, 2004; doi:10.1152/physiolgenomics.00148.2004
1094-8341/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
19/3/292    most recent
00148.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spin, J. M.
Right arrow Articles by Quertermous, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spin, J. M.
Right arrow Articles by Quertermous, T.
Received 30 June 2004; accepted in final form 24 August 2004.
Physiological Genomics 19:292-302 (2004)
1094-8341/04 $5.00 © 2004 American Physiological Society

Transcriptional profiling of in vitro smooth muscle cell differentiation identifies specific patterns of gene and pathway activation

Joshua M. Spin, Shriram Nallamshetty, Raymond Tabibiazar, Euan A. Ashley, Jennifer Y. King, Mary Chen, Phillip S. Tsao and Thomas Quertermous

Donald W. Reynolds Cardiovascular Clinical Research Center, Stanford University School of Medicine, Stanford, California

Mesodermal and epidermal precursor cells undergo phenotypic changes during differentiation to the smooth muscle cell (SMC) lineage that are relevant to pathophysiological processes in the adult. Molecular mechanisms that underlie lineage determination and terminal differentiation of this cell type have received much attention, but the genetic program that regulates these processes has not been fully defined. Study of SMC differentiation has been facilitated by development of the P19-derived A404 embryonal cell line, which differentiates toward this lineage in the presence of retinoic acid and allows selection for cells adopting a SMC fate through a differentiation-specific drug marker. We sought to define global alterations in gene expression by studying A404 cells during SMC differentiation with oligonucleotide microarray transcriptional profiling. Using an in situ 60-mer array platform with more than 20,000 mouse genes derived from the National Institute on Aging clone set, we identified 2,739 genes that were significantly upregulated after differentiation was completed (false-detection ratio <1). These genes encode numerous markers known to characterize differentiated SMC, as well as many unknown factors. We further characterized the sequential patterns of gene expression during the differentiation time course, particularly for known transcription factor families, providing new insights into the regulation of the differentiation process. Changes in genes associated with specific biological ontology-based pathways were evaluated, and temporal trends were identified for functional pathways. In addition to confirming the utility of the A404 model, our data provide a large-scale perspective of gene regulation during SMC differentiation.

gene expression; microarray




This article has been cited by other articles:


Home page
Mol. Interv.Home page
D. I. Diz
Future Directions in Cardiovascular Pharmacology: Examples from the Renin-Angiotensin System
Mol. Interv., October 1, 2008; 8(5): 222 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. A. Ashley, J. M. Spin, R. Tabibiazar, and T. Quertermous
Frontiers in Nephrology: Genomic Approaches to Understanding the Molecular Basis of Atherosclerosis
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2853 - 2862.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. M. Shirvani, L. Mookanamparambil, M. F. Ramoni, and M. T. Chin
Transcription factor CHF1/Hey2 regulates the global transcriptional response to platelet-derived growth factor in vascular smooth muscle cells
Physiol Genomics, June 19, 2007; 30(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. E. Clempus, D. Sorescu, A. E. Dikalova, L. Pounkova, P. Jo, G. P. Sorescu, B. Lassegue, and K. K. Griendling
Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 42 - 48.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. C. Wu, J. M. Spin, F. Cao, S. Lin, X. Xie, O. Gheysens, I. Y. Chen, A. Y. Sheikh, R. C. Robbins, A. Tsalenko, et al.
Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation
Physiol Genomics, March 13, 2006; 25(1): 29 - 38.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Gorenne, L. Jin, T. Yoshida, J.M. Sanders, I.J. Sarembock, G.K. Owens, A.P. Somlyo, and A.V. Somlyo
LPP Expression During In Vitro Smooth Muscle Differentiation and Stent-Induced Vascular Injury
Circ. Res., February 17, 2006; 98(3): 378 - 385.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. Y. King, R. Ferrara, R. Tabibiazar, J. M. Spin, M. M. Chen, A. Kuchinsky, A. Vailaya, R. Kincaid, A. Tsalenko, D. X.-F. Deng, et al.
Pathway analysis of coronary atherosclerosis
Physiol Genomics, September 21, 2005; 23(1): 103 - 118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.